Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials : proceedings of a workshop /

Saved in:
Bibliographic Details
Author / Creator:Anderson, Karen M., rapporteur.
Imprint:Washington, DC : The National Academies Press, [2016]
Description:1 online resource (1 PDF file (xiii, 69 pages)) : illustrations.
Language:English
Subject:Clinical Trials as Topic.
Healthcare Disparities.
Patient Selection.
Communication Barriers.
Minority Groups.
Ethnic Groups.
Women.
Clinical trials.
Discrimination in medical care.
Health services accessibility.
HEALTH & FITNESS / Diseases / General
MEDICAL / Clinical Medicine
MEDICAL / Diseases
MEDICAL / Evidence-Based Medicine
MEDICAL / Internal Medicine
Clinical trials.
Discrimination in medical care.
Health services accessibility.
United States.
Congresses.
Electronic books.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11265733
Hidden Bibliographic Details
Other authors / contributors:Olson, Steve, 1956- rapporteur.
National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities.
National Academies of Sciences, Engineering, and Medicine (U.S.), issuing body.
Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop) (2015 : Washington, D.C.)
ISBN:9780309443579 (pbk.)
0309443571 (pbk.)
9780309443586
030944358X
Notes:Includes bibliographical references.
This activity was supported by the Aetna Foundation, Health Resources and Services Administration, Kaiser Permanente, The Kresge Foundation, Merck & Co., Inc., Methodist Health Ministries, and Office of Minority Health, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
Description based on online resource; title from PDF title page (viewed October 18, 2016).
Summary:Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the overall population of minorities in the United States. This underrepresentation threatens the health of both these populations and the general population, since greater minority representation could reveal factors that affect health in all populations. Federal legislation has sought to increase the representation of minorities and women in clinical trials, but legislation by itself has not been sufficient to overcome the many barriers to greater participation. Only much broader changes will bring about the meaningful participation of all population groups in the clinical research needed to improve health. To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the National Academies of Sciences, Engineering, and Medicine held a workshop in April 2015. This publication summarizes the presentations and discussions from the workshop.
Other form:Print version: Anderson, Karen M. Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials Washington, D.C. : National Academies Press, 2016
Standard no.:10.17226/23530